1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF784 CTRPv2 pan-cancer AAC 0.19 3e-08
mRNA ZNF786 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA ZNF8 CTRPv2 pan-cancer AAC 0.23 2e-09
mRNA ZNF821 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ZNF84 CTRPv2 pan-cancer AAC 0.19 9e-08
mRNA ZNF850 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA ZNF852 CTRPv2 pan-cancer AAC 0.16 9e-05
mRNA ZNF853 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA ZNF865 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ZNF891 CTRPv2 pan-cancer AAC 0.13 0.0005
Download CSV